Trademark Overview
On Sunday, May 22, 2022, a trademark application was filed for H HIRO with the United States Patent and Trademark Office. The USPTO has given the H HIRO trademark a serial number of 97423106. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 7, 2023. This trademark is owned by Shanghai Harvest Medical Technology Co., Ltd.. The H HIRO trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Advertising and publicity services; Business investigations; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business management consultancy as well as development of processes for the analysis and the implementation of strategy plans and management projects; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Market analysis; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Sales promotion for others; Analysis of business data; Collecting and analyzing claims data from healthcare organizations for business purposes; Compiling and analyzing statistics, data and other sources of information for business...
Computer software design; Electronic data storage; Medical research; Medical research services; Pharmaceutical research services; Pharmaceutical product evaluation; Research on the subject of pharmaceuticals; Scientific investigations for medical purposes; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conversion of computer programs and data, other than physical conversion; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Scientific research in the nature of conducting clinical trials for others
